Publikationen von M. Götz

Groll, M.; Götz, M.; Kaiser, M.; Weyher, E.; Moroder, L.: TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome. Chemistry & Biology 13 (6), S. 607 - 614 (2006)

Cappello, S.; Attardo, A.; Wu, X.; Iwasato, T.; Itohara, S.; Wilsch-Brauninger, M.; Eilken, H. M.; Rieger, M. A.; Schroeder, T. T.; Huttner, W. et al.; Brakebusch, C.; Götz, M.: The Rho GTPase cdc42 regulates neural progenitor fate at the apical surface. Nat. Neurosci. 9, S. 1099 - 1107 (2006)

Moroder, L.; Musiol, H. J.; Götz, M.; Renner, C.: Synthesis of single- and multiple-stranded cystine-rich peptides. Biopolymers 80 (2-3), S. 85 - 97 (2005)

Götz, M.; Musiol, H.-J.; Moroder, L.: Multiple-Strand Cystine Peptides. In: Oxidative folding of peptides and proteins, S. 367 - 380 (Hg. Buchner, J.; Moroder, L.). Royal Society of Chemistry, Cambridge (2009)

Barazza, A.; Götz, M.; Renner, C.; Willem, M.; Moroder, L.: Cyclic statine-based peptides as inhibitors of β-secretase. In: Understanding Biology Using Peptides, S. 385 - 386 (Hg. Blundelle, S.). Springer, New York (2005)

Kaiser, M.; Groll, M.; Götz, M.; Siciliano, C.; Assfalg-Machleidt, I.; Weyher, E.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R. et al.; Moroder, L.: Structural determinants for 20S proteasome inhibition by TMC-95A. In: Peptides 2004, S. 657 - 658 (Hg. Flegel, M.; Fridkin, M.; Gilon, C.; Slaninovva, J.). Kenes International, Geneva/Switzerland (2005)

Kaiser, M.; Groll, M.; Siciliano, C.; Götz, M.; Assfalg-Machleidt, I.; Kohno, J.; Milbradt, A. G.; Renner, C.; Huber, R.; Moroder, L.: Inhibition of yeast 20S proteasome by biaryl- and biaryl ether cross-bridged tripeptide derivatives as TMC-95A analogs. In: Peptides – Biology and Chemistry, S. 201 - 225 (Hg. Liu, K.-L.; J. P., T.). Science Press, USA (2005)